Sign in
4

Changes in Ownership

Mereo BioPharma Group plc Filed Acc 0001193125-26-033751

Options or other derivatives

  • Chief Executive Officer acquired 1,860,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Scots-Knight Denise Chief Executive Officer 2026-02-01 Grant or award · Share Options (Right to buy) +1,035,000 1,035,000 D: show line 1 in the form
Scots-Knight Denise Chief Executive Officer 2026-02-01 Grant or award · Share Options (Right to buy) +345,000 345,000 D: show line 2 in the form
Scots-Knight Denise Chief Executive Officer 2026-02-01 Grant or award · Share Options (Right to buy) +480,000 480,000 D: show line 3 in the form
Loading xslF345X05/ownership.xml…